Clinical Trials Browser

Phase 1/2 × Brain Neoplasms × Vorinostat × Clear all

NCT01110876 2021-08-25

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Phase 1/2 Terminated

21 enrolled 8 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00939991 2013-06-24

Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas

Phase 1/2 Completed

48 enrolled 12 charts

Brain Neoplasms, Glioblastoma